Clinical Research Directory
Browse clinical research sites, groups, and studies.
Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR)
Sponsor: NHS Greater Glasgow and Clyde
Summary
Rheumatoid arthritis is an autoimmune condition, causing inflammation and pain. Yet pain may persist even when inflammation has been treated. This residual pain, called nociplastic pain, has symptoms of a chronic pain condition called fibromyalgia. There are few effective therapies to address this residual pain. Published literature shows that fibromyalgia can be treated by neurofeedback, a noninvasive method that is based on the voluntary modulation of cortical activity. In this pilot study, the investigators want to test the effect of neurofeedback on the fibromyalgia component of pain in rheumatoid arthritis, and also to investigate its effects on related symptoms such as fatigue and sleep disturbance.
Official title: Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2024-06-24
Completion Date
2027-01-29
Last Updated
2025-06-15
Healthy Volunteers
No
Interventions
Neurofeedback
A noninvasive method based on the voluntary modulation of brain activity, with feedback provided through a graphical user interface shown on a computer screen
Locations (1)
Clinical Research Facility (CRF), Queen Elizabeth University Hospital
Glasgow, Scotland, United Kingdom